Exploratory examination of inflammation state, immune response and blood cell composition in a human obese cohort to identify potential markers predicting cancer risk

• Published in: PloS one 2020-02, Vol.15 (2), p.e0228633-e0228633
• Main Authors: Elisia, Ingrid, Lam, Vivian, Cho, Brandon, Hay, Mariah, Li, Michael Yu, Kapeluto, Jordanna, Elliott, Tom, Harris, David, Bu, Luke, Jia, William, Leung, Hilary, Mohn, William, Krystal, Gerald
• Format: Article
• Language: English
• Subjects: Adaptive immunity; Adult; Biology and Life Sciences; Biomarkers - blood; Blood; Blood Cells; Cancer; Case-Control Studies; CD28 antigen; CD3 antigen; CD4 antigen; CD8 antigen; Cell activation; Chemokines; Chronic diseases; Chronic illnesses; Cohort Studies; Composition; Cytokines; Development and progression; Diabetes mellitus; Diabetes mellitus (non-insulin dependent); Diseases; E coli; EDTA; Endothelial growth factors; Epidemics; Erythrocytes; Female; Granulocyte colony-stimulating factor; Health aspects; Health risks; Humans; Immune response; Immune system; Immunity; Inflammation; Interleukin 1 receptor antagonist; Interleukin 1 receptors; Interleukin 17; Interleukin 6; Interleukin 8; Laboratories; Leukocytes (granulocytic); Lymphocytes; Lymphocytes T; Male; Markers; Medicine and Health Sciences; Monocytes; Natural killer cells; Neoplasms - blood; Neoplasms - etiology; Obesity; Obesity - blood; Obesity - complications; Parameter identification; Prostaglandin E2; Risk; Risk Assessment; Risk factors; T cells; Tumor cells; Tumors; Type 2 diabetes; Vascular endothelial growth factor; Viral infections; γ-Interferon
• ISSN: 1932-6203; 1932-6203
• DOI: 10.1371/journal.pone.0228633

Obesity has reached epidemic proportions and is often accompanied by elevated levels of pro-inflammatory cytokines that promote many chronic diseases, including cancer. However, not all obese people develop these diseases and it would be very helpful to identify those at high risk early on so that preventative measures can be instituted. We performed an extensive evaluation of the effects of obesity on inflammatory markers, on innate and adaptive immune responses, and on blood cell composition to identify markers that might be useful in distinguishing those at elevated risk of cancer. Plasma samples from 42 volunteers with a BMI>35 had significantly higher CRP, PGE2, IL-1RA, IL-6 and IL-17 levels than 34 volunteers with normal BMIs. Of the cytokines and chemokines tested, only IL-17 was significantly higher in men with a BMI>35 than women with a BMI>35. As well, only IL-17 was significantly higher in those with a BMI>35 that had type 2 diabetes versus those without type 2 diabetes. Whole blood samples from participants with a BMI>35, when challenged with E. coli, produced significantly higher levels of IL-1RA while HSV-1 challenge resulted in significantly elevated IL-1RA and VEGF, and a non-significant increase in G-CSF and IL-8 levels. T cell activation of PBMCs, via anti-CD3 plus anti-CD28, resulted in significantly higher IFNγ production from volunteers with a BMI>35. In terms of blood cells, red blood cell distribution width (RDW), monocytes, granulocytes, CD4+T cells and Tregs were all significantly higher while, natural killer (NK) and CD8+ T cells were all significantly lower in the BMI>35 cohort, suggesting that obesity may reduce the ability to kill nascent tumor cells. Importantly, however, there was considerable person-to-person variation amongst participants with a BMI>35, with some volunteers showing markedly different values from controls and others showing normal levels of many parameters measured. These person-to-person variations may prove useful in identifying those at high risk of developing cancer.